Open Access

Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo


Cite

1. C. Cerchia and A. Lavecchia, Small molecule drugs and targeted therapy for melanoma: Current strategies and future directions, Curr. Med. Chem. 24 (2017) 1–33; https://doi.org/10.2174/092986732466617041416393710.2174/092986732466617041416393728413965Search in Google Scholar

2. T. Zhang, Y. R. Suryawanshi, H. M. Woyczesczyk and K. Essani, Targeting melanoma with cancerkilling viruses, Open. Virol. J. 11 (2017) 28–47; https://doi.org/10.2174/187435790171101002810.2174/1874357901711010028542017228567163Search in Google Scholar

3. P. Diamantopoulos and H. Gogas, Melanoma immunotherapy dominates the field, Ann. Transl. Med.4 (2016) 269; https://doi.org/10.21037/atm.2016.06.3210.21037/atm.2016.06.32497137927563656Search in Google Scholar

4. A. A. Tarhini and S. S. Agarwala, Cutaneous melanoma: available therapy for metastatic disease, Dermatol. Ther. 19 (2010) 19–25; https://doi.org/10.1111/j.1529-8019.2005.00052.x10.1111/j.1529-8019.2005.00052.x16405566Search in Google Scholar

5. P. C. Bruijnincx and P. J. Sadler, New trends for metal complexes with anticancer activity, Curr. Opin. Chem. Biol.12 (2008) 197–206; https://doi.org/10.1016/j.cbpa.2007.11.01310.1016/j.cbpa.2007.11.013292302918155674Search in Google Scholar

6. Y. Jung and S. J. Lippard, Direct cellular responses to platinum-induced DNA damage, Chem. Rev. 107 (2010) 1387–407; https://doi.org/10.1002/chin.20073127010.1002/chin.200731270Search in Google Scholar

7. M. S. Soengas and S. W. Lowe, Apoptosis and melanoma chemoresistance, Oncogene22 (2003) 3138–3151; https://doi.org/10.1038/sj.onc.120645410.1038/sj.onc.120645412789290Search in Google Scholar

8. I. E. León, V. Porro, S. Astrada, M. G. Egusquiza, C. I. Cabello, M. Bollati-Fogolin and S. B. Etcheverry, Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model, Chem. Biol. Interact. 222 (2014) 87–96; https://doi.org/10.1016/j.cbi.2014.10.01210.1016/j.cbi.2014.10.01225451568Search in Google Scholar

9. J. Zhao, S. Gou and F. Liu, Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand, Chemistry20 (2014) 15216–15225; https://doi.org/10.1002/chem.20140409010.1002/chem.20140409025256173Search in Google Scholar

10. S. Iglesias, N. Alvarez, M. H. Torre, E. Kremer, J. Ellena, R. R. Ribeiro, R. P. Barroso, A. J. Costafilho, M. G. Kramer and G. Facchin, Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper complexes for the treatment of cancer, J. Inorg. Biochem. 139 (2014) 117–123; https://doi.org/10.1016/j.jinorgbio.2014.06.00710.1016/j.jinorgbio.2014.06.00725033418Search in Google Scholar

11. J. Lv, T. T. Liu, S. L. Cai, X. Wang, L. Liu and Y. M. Wang, Synthesis, structure and biological activity of cobalt (ii) and copper (ii) complexes of valine-derived Schiff bases, J. Inorg. Biochem.100 (2006) 1888–1896; https://doi.org/10.1016/j.jinorgbio.2006.07.01410.1016/j.jinorgbio.2006.07.01416965817Search in Google Scholar

12. V. M. Leovac, G. A. Bogdanović, L. S. Jovanović, L. Joksović, V. Marković, M. D. Joksović, S. M. Denčić, A. Isaković, I. Marković and F. W. Heinemann, Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl--3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde, J. Inorg. Biochem.105 (2011) 1413–1421; https://doi.org/10.1016/j.jinorgbio.2011.07.02110.1016/j.jinorgbio.2011.07.02121955843Search in Google Scholar

13. X. Q. Zhou, Y. Li, D. Y. Zhang, Y. Nie, Z. J. Li, W. Gu, X. Liu, J. L. Tian and S. P. Yan, Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis, Eur. J. Med. Chem. 114 (2016) 244–256; https://doi.org/10.1016/j.ejmech.2016.02.05510.1016/j.ejmech.2016.02.05526994692Search in Google Scholar

14. X. H. Wang, D. Z. Jia, Y. J. Liang, S. L. Yan, Y. Ding, L. M. Chen, Z. Shi, M. S. Zeng, G. F. Liu and L. W. Fu, Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway, Cancer. Lett. 249 (2007) 256–270; https://doi.org/10.1016/j.canlet.2006.09.00810.1016/j.canlet.2006.09.00817055640Search in Google Scholar

15. C. Kou, J. Zhao, Y. Li, G. Xu and S. Sun, Acute toxicity test of different doses of copper complex of pyrazolone derivatives in mice, Chin. Hosp. Pharm. J. 36 (2016) 821–825 (In Chinese).Search in Google Scholar

16. G. C. Xu, L. Zhang, L. Liu, G. F. Liu and D. Z. Jia, Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of (1-phenyl-3-methyl-4-propenylidene-5--pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand, Polyhedron27 (2008) 12–24; https://doi.org/10.1016/j.poly.2007.08.04510.1016/j.poly.2007.08.045Search in Google Scholar

17. J. Zhao, L. Zhang, J. Li, T. Wu, M. Wang, G. Xu, F. Zhang, L. Liu, J. Yang and S. Sun, A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway, Chem. Biol. Interact. 231 (2015) 1–9; https://doi.org/10.1016/j.cbi.2015.02.00410.1016/j.cbi.2015.02.00425684395Search in Google Scholar

18. Q. L. Wu, X. P. Wu, Y. J. Liang, L. M. Chen, Y. Ding and L. W. Fu, P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells, World. J. Gastroenterol.11 (2005) 3544; https://doi.org/10.3748/wjg.v11.i23.354410.3748/wjg.v11.i23.3544431595715962371Search in Google Scholar

19. C. Chang, T. Wu, M. Wang, G. Xu and S. Sun, Antitumor effect of cadmium(II) complex of pyrazolone derivatives on melanoma B16 cells in vitro and in vivo, Chin. J. Pharmacol. Toxicol. 31 (2017) 405–413 (In Chinese).Search in Google Scholar

20. G. Resta, G. Anania, F. Messina, D. D. Tullio, G. Ferrocci, F. Zanzi, D. Pellegrini, R. Stano, G. Cavallesco, G. Azzena and S. Occhionorelli, Jejuno-jejunal invagination due to intestinal melanoma, World. J. Gastroenterol. 13 (2007) 310; https://doi.org/10.3748/wjg.v13.i2.31010.3748/wjg.v13.i2.310406596417226915Search in Google Scholar

21. A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M. L. Kuppusamy, S. Naidu, T. Ka´lai, K. Hideg and P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function complex, J. Pharmacol. Exp. Ther. 339 (2011) 350–357; https://doi.org/10.1124/jpet.111.18368110.1124/jpet.111.183681319999421799049Search in Google Scholar

22. H. Yang, D. Chen, Q. C. Cui, X. Yuan and Q. P. Dou, Celastrol, a triterpene extracted from the chinese “thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer. Res. 66 (2006) 4758; https://doi.org/10.1158/0008-5472.can-05-452910.1158/0008-5472.CAN-05-452916651429Search in Google Scholar

23. W. Jiang, J. Cao, B. Pan and Y. Yu, Clinical significance of serum vascular endothelial growth factor and b-fibroblast growth factor before and after chemotherapy in patients with small cell lung cancer, Chin. J. Clin. Oncol. 40 (2013) 638–642; https://doi.org/10.3969/j.issn.1000-8179.2013.11.006Search in Google Scholar

24. S. Imura, H. Miyake, K. Izumi, S. Tashiro and H. Uehara, Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma, J. Med. Invest. 51 (2004) 202; https://doi.org/10.2152/jmi.51.20210.2152/jmi.51.20215460907Search in Google Scholar

25. H. Yao, P. Cui, D. Xu, Y. Liu, Q. Tian and F. Zhang, A water-soluble polysaccharide from the roots of Polygala tenuifolia suppresses ovarian tumor growth and angiogenesis in vivo, Int. J. Biol. Macromol.107 (2018) 713–718; https://doi.org/10.1016/j.ijbiomac.2017.09.04310.1016/j.ijbiomac.2017.09.04328923567Search in Google Scholar

eISSN:
1846-9558
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, other